TransCode Therapeutics, Inc. Common Stock

RNAZ us
$1.69
▲ +0.04 (+2.42%)
Volume: 14,759 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 13
  • 21d momentum -27.8%
  • MA aligned bearish
  • RSI 29 oversold
🎯 Pullback 56
  • RSI 29 near lows
  • -7.1% vs 20MA
💎 Value 58
  • -92% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)28.9
MACD+0.114
MA trendBearish
ATR17.00%
21d mom.-27.8%
63d mom.-62.9%
vs 20MA-7.1%
RVOL(20)0.15×
52w low · 2 52w high · 21
-92.0% from 52-week high
20d support 2 · resistance 2

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$28M
PER—
PBR-1.01
PSR—
EPS$-2.73
ROE167.1%
ROA-30.6%
Dividend yield0.00%
Debt/Equity-0.02
EV/EBITDA-0.56
week1M3M6M1YYTD
+2.42% -27.78% -62.86% -80.14% -85.14% -77.16%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
1/10
🐻 Bear
10/10

14d momentum -17.96%, daily vol 4.03%. TransCode Therapeutics, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.